- Home
- RLAY vs PBT Comparison
RLAY vs PBT Comparison
Compare RLAY & PBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- PBT
- Stock Information
- Founded
- RLAY 2015
- PBT 1980
- Country
- RLAY United States
- PBT United States
- Employees
- RLAY N/A
- PBT N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- PBT Oil & Gas Production
- Sector
- RLAY Health Care
- PBT Energy
- Exchange
- RLAY Nasdaq
- PBT Nasdaq
- Market Cap
- RLAY 610.3M
- PBT 740.1M
- IPO Year
- RLAY 2020
- PBT N/A
- Fundamental
- Price
- RLAY $3.54
- PBT $15.83
- Analyst Decision
- RLAY Strong Buy
- PBT
- Analyst Count
- RLAY 12
- PBT 0
- Target Price
- RLAY $18.45
- PBT N/A
- AVG Volume (30 Days)
- RLAY 2.8M
- PBT 159.4K
- Earning Date
- RLAY 08-07-2025
- PBT 01-01-0001
- Dividend Yield
- RLAY N/A
- PBT 3.37%
- EPS Growth
- RLAY N/A
- PBT N/A
- EPS
- RLAY N/A
- PBT 0.35
- Revenue
- RLAY $8,355,000.00
- PBT $18,413,820.00
- Revenue This Year
- RLAY $17.59
- PBT N/A
- Revenue Next Year
- RLAY N/A
- PBT N/A
- P/E Ratio
- RLAY N/A
- PBT $44.91
- Revenue Growth
- RLAY N/A
- PBT N/A
- 52 Week Low
- RLAY $1.78
- PBT $8.01
- 52 Week High
- RLAY $10.72
- PBT $16.65
- Technical
- Relative Strength Index (RSI)
- RLAY 52.25
- PBT 73.50
- Support Level
- RLAY $3.31
- PBT $15.43
- Resistance Level
- RLAY $3.61
- PBT $13.70
- Average True Range (ATR)
- RLAY 0.21
- PBT 0.68
- MACD
- RLAY -0.02
- PBT 0.12
- Stochastic Oscillator
- RLAY 68.67
- PBT 77.84
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About PBT Permian Basin Royalty Trust
Permian Basin Royalty Trust is an express trust. The company's underlying properties include Waddell Ranch Properties in which the trust holds mineral interest as well as royalty interests in mature producing oil fields, such as Yates, Wasson, Sand Hills, East Texas, Kelly-Snyder, Panhandle Regular, N. Cowden, Todd, Keystone, Kermit, McElroy, Howard-Glasscock, Seminole and others across Texas. The company earns majority revenue in form of royalties received through its properties.